We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$141B
1-Year Est. Return
34.18%
This Fund
S&P 500
This Quarter
Est. Return
-2.16%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+619.19%
AUM
$99.1B
AUM Growth
-$5.32B
(-5.1%)
Cap. Flow
-$740M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
27.72%
Holding
1,277
New
83
Increased
445
Reduced
587
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$927M |
| 2 |
Broadcom
AVGO
|
+$406M |
| 3 |
Blackrock
BLK
|
+$362M |
| 4 |
Carrier Global
CARR
|
+$224M |
| 5 |
Lam Research
LRCX
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$325M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
GE Vernova
GEV
|
+$283M |
| 4 |
NVIDIA
NVDA
|
+$280M |
| 5 |
Zebra Technologies
ZBRA
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.33% |
| 2 | Financials | 13.48% |
| 3 | Communication Services | 12.67% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
American Vanguard Corp
AVD
$62.8M
| $1.67M | ﹤0.01% |
376,358
-147,086
| -28% | -$750K |
|
902
National Health Investors
NHI
$3.49B
| $1.66M | ﹤0.01% |
22,497
+230
| +1% | +$16.2K |
|
903
HEICO Corp Class A
HEI.A
$38B
| $1.65M | ﹤0.01% |
7,896
+12
| +0.2% | +$2.33K |
|
|
NVO
904
Novo Nordisk
NVO
$205B
| $1.64M | ﹤0.01% |
23,615
+17,210
| +269% | +$1.42M |
|
905
Zimmer Biomet
ZBH
$19B
| $1.58M | ﹤0.01% |
14,060
-3,251
| -19% | -$348K |
|
906
Euronet Worldwide
EEFT
$2.78B
| $1.57M | ﹤0.01% |
14,656
-3,944
| -21% | -$400K |
|
907
Conagra Brands
CAG
$7.39B
| $1.56M | ﹤0.01% |
58,745
-110,283
| -65% | -$2.85M |
|
908
Matsons
MATX
$6.42B
| $1.55M | ﹤0.01% |
12,203
+6,943
| +132% | +$952K |
|
909
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $1.54M | ﹤0.01% |
+30,030
| New | +$1.52M |
|
910
CDW
CDW
$17.8B
| $1.54M | ﹤0.01% |
9,521
-10,373
| -52% | -$1.88M |
|
911
Principal Financial Group
PFG
$24.6B
| $1.52M | ﹤0.01% |
18,274
-47,762
| -72% | -$3.97M |
|
912
Columbia Sportswear
COLM
$2.95B
| $1.51M | ﹤0.01% |
20,007
-3,419
| -15% | -$285K |
|
913
EyePoint Inc
EYPT
$1.15B
| $1.5M | ﹤0.01% |
257,985
-12,351
| -5% | -$86.4K |
|
|
MRUS
914
DELISTED
Merus
MRUS
| $1.47M | ﹤0.01% |
32,917
| – | – |
|
|
PPL
915
PPL Corp
PPL
$26.8B
| $1.46M | ﹤0.01% |
41,013
-411
| -1% | -$13.9K |
|
916
Teradyne
TER
$64.2B
| $1.46M | ﹤0.01% |
17,628
-409
| -2% | -$45.8K |
|
917
iShares Global Tech ETF
IXN
$9.47B
| $1.45M | ﹤0.01% |
19,145
+2,400
| +14% | +$199K |
|
918
Ionis Pharmaceuticals
IONS
$9.29B
| $1.43M | ﹤0.01% |
45,950
-54,709
| -54% | -$1.79M |
|
919
Clorox
CLX
$12.9B
| $1.43M | ﹤0.01% |
9,770
-1,302
| -12% | -$199K |
|
920
Loews
L
$23.1B
| $1.43M | ﹤0.01% |
15,761
+1,897
| +14% | +$162K |
|
921
Valmont Industries
VMI
$9.46B
| $1.42M | ﹤0.01% |
4,904
+196
| +4% | +$63.9K |
|
922
Bank of America Series L
BAC.PRL
$4.01B
| $1.34M | ﹤0.01% |
1,096
-245
| -18% | -$301K |
|
|
ZBIO
923
Zenas BioPharma
ZBIO
$1.84B
| $1.34M | ﹤0.01% |
164,035
-7,905
| -5% | -$61.9K |
|
924
Tyler Technologies
TYL
$13.5B
| $1.33M | ﹤0.01% |
2,301
-252
| -10% | -$150K |
|
925
Watts Water Technologies
WTS
$12.8B
| $1.32M | ﹤0.01% |
6,456
+416
| +7% | +$87.2K |
|
Similar funds
VAM
Schroder Investment Management Group's Q1 2025 Portfolio in Review
As of Q1 2025, Schroder Investment Management Group held 1,277 positions worth $99.1B, down 5.1% from $104B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Schroder Investment Management Group's Q1 2025 filing shows 83 new, 445 increased, 587 reduced and 91 closed positions. Its largest new stake was Arista Networks: 9,143,531 shares worth $708M. The largest sale was Merck, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.
- Schroder Investment Management Group's largest Q1 2025 buy was Arista Networks: 9,143,531 shares worth $708M.
- Schroder Investment Management Group added most to Broadcom in Q1 2025, an estimated $406M increase.
- Schroder Investment Management Group's biggest Q1 2025 reduction was Merck, cutting an estimated $325M.
- Schroder Investment Management Group fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $62M.
- Schroder Investment Management Group's ten largest holdings make up 28% of its $99.1B portfolio in Q1 2025.
- Schroder Investment Management Group opened 83 new positions and closed 91 in Q1 2025.
- Schroder Investment Management Group's portfolio value fell 5.1% quarter-over-quarter to $99.1B.
Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.